In an experimental bone metastasis model of prostate cancer, prostate cancer cells target the hematopoietic stem cell (HSC) niche, use the CXCL12–CXCR4 axis to home to the niche, and compete with the HSC cells for niche support [55]. This evidence concerns the gene CXCR4 and Familial prostate cancer.